10d
Zacks Investment Research on MSNHere's Why you Should Retain Nevro Stock in Your Portfolio NowNevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring ...
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
24d
Zacks.com on MSNNevro Q4 Earnings & Revenues Beat Estimates, Gross Margin DownIn addition to the U.S. market release, Nevro introduced the HFX iQ SCS system in select European ... and weight loss in ...
Nevro’s comprehensive HFX™ spinal cord stimulation (SCS ... of chronic pain of the trunk and limb and painful diabetic neuropathy. Nevro also offers minimally invasive treatment options ...
Launched the HFX iQ SCS system in select European countries ... chronic pain of the trunk and limb and painful diabetic neuropathy. Nevro also offers minimally invasive treatment options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results